Chapter

Mesenchymal Stem/Stromal Cells as Cellular Vehicles for Tumor Targeting

07/2010; DOI:10.1007/978-1-4419-6102-0_8 pp.113-139

ABSTRACT Data published over the last 10 years suggest that mesenchymal stem/stromal cells (MSC) possess the innate capacity to home
to sites of inflammation, including tumors and wounding microenvironments. Evidence suggests that the increased production
of inflammatory mediators found at these sites is potential attractants for recruitment and engraftment. This innate homing
response can be exploited by using MSC as a cellular delivery vehicle to deliver anticancer agents directly to tumors. The
high-level intratumoral production of these agents controls tumor growth and prolongs survival in numerous animal models.
In this review, we examine the ability of MSC to selectively home to and engraft within the tumor microenvironment and the
multiple gene products delivered by MSC when used as delivery vehicles for anticancer therapies.

KeywordsCarcinoma-Associated Fibroblast (CAF)-Tumor Microenvironment-Tumor homing-Tumor stroma-Interferon-beta

0 0
 · 
0 Bookmarks
 · 
21 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

agents controls tumor growth
 
anticancer therapies
 
CAF)-Tumor Microenvironment-Tumor homing-Tumor stroma-Interferon-beta
 
cellular delivery vehicle
 
delivery vehicles
 
engraft
 
engraftment
 
high-level intratumoral production
 
inflammatory mediators
 
innate capacity
 
KeywordsCarcinoma-Associated Fibroblast
 
last 10 years
 
multiple gene products
 
numerous animal models
 
tumors